Methods and compounds for muscle growth

Details for Australian Patent Application No. 2011214465 (hide)

Owner Novartis AG

Inventors Glass, David; Shi, Jun

Agent Davies Collison Cave

Pub. Number AU-A-2011214465

PCT Pub. Number WO2011/098449

Priority 61/303,027 10.02.10 US

Filing date 8 February 2011

Wipo publication date 18 August 2011

International Classifications

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/098449 Priority application(s): WO2011/098449

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011214468-6-amino-2-{ [ (1S)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8Hpurin-8-one maleate

2011214464-Use of isorhamnetin triglycosides